Neuroprotection study for recent acute ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests whether an investigational treatment can protect brain cells in people who recently had an ischemic stroke (a blockage in a brain artery). The goal is to see if the treatment improves recovery and reduces long-term disability.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You had an ischemic stroke within the last 48 hours (when symptoms started or when you were last seen well).
- Your stroke must be in the middle cerebral artery area of the brain.
- Your stroke must be moderate to severe, as measured by a standard test called the NIHSS (score of 6 or more).
- You must not have had a prior stroke that left you with any disability (modified Rankin score of 0 or 1 before this stroke).
- You cannot be taking certain medications (memantine, ketamine, lamotrigine) or have epilepsy, seizures, or certain bleeding in the brain.
- If you are a woman who can get pregnant, you must not be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug given by IV to help people recover arm and leg movement after a severe stroke. It may help improve recovery in the early weeks after a stroke.
This study tests a combination of gentle brain-protecting treatments (temperature, oxygen, positioning, and nerve stimulation) given alongside standard clot-busting therapy for recent strokes. The goal is to see if the combination can help improve recovery and reduce disability after a stroke.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This trial tests a medical device for treating acute ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The device is used along with standard care to try to improve recovery and reduce disability.
This study tests a rescue treatment for people having a major stroke caused by a blocked artery in the brain that also has severe narrowing. If doctors can't fully open the artery with standard clot removal, this study looks at whether additional treatments can help.
This study tests an investigational injectable drug called LT3001 that may help dissolve blood clots in the brain after a stroke. It is given within 24 hours of stroke onset, and the goal is to reduce disability and improve recovery.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.